Skip to main content

Table 1 Characteristics of probable IPA in critically ill COPD patients (n = 9)

From: Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study

 

Age

(years)

Risk

factors

The length from symptoms to ICU admission (day)

APACHE II scores

Samples of fungal culture

Aspergillus species

Serum GM

BALF GM

The time of antifungal treatment after ICU admission

Cause of death

       

Day 1

Day 4

Day 7

   

1

76

Antibiotics steroid

13

14

ETA

none

0.298

0.503

1.321

4.508

Day 2

MOF

2

52

Antibiotics steroid

20

15

ETA

A. fumigatus

0.296

0.484

-

0.322

Day 3

RF

3

74

Antibiotics steroid

11

15

ETA

BALF

A. fumigatus &A. flavus

0.626

3.170

-

6.374

Day 2

MOF, SS

4

49

Antibiotics

24

15

ETA

none

1.606

1.302

-

1.098

Day 1

MOF

5

87

Antibiotics

17

7

ETA

none

0.867

2.499

-

1.510

Day 5

MOF, SS

6

71

Antibiotics steroid

7

10

ETA

A. fumigatus

0.562

0.620

-

0.850

Day 6

RF

7

81

Antibiotics steroid

30

15

ETA

A. fumigatus &A. versicolor

1.081

2.032

-

2.609

Day 2

MOF

8

59

Antibiotics

60

14

ETA

A. fumigatus

1.432

-

-

4.057

Day 1

MOF, SS

9

65

Antibiotics steroid

10

18

ETA

BALF

A. fumigatus &A. fiavus

1.072

0.533

-

4.619

Day 1

MOF

  1. APACHE II, Acute Physiology and Chronic Health Evaluation II; BALF, bronchoalveolar lavage fluid; GM, galactomannan, MOF, multiple organ failure; RF, renal failure; SS, septic shock.